Редактирование: BMP4

Bone morphogenetic protein 4 precursor (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B) [BMP2B] [DVR4]

==Publications==

{{medline-entry
|title=Direct reprogramming of human smooth muscle and vascular endothelial cells reveals defects associated with aging and Hutchinson-Gilford progeria syndrome.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32896271
|abstract=Vascular dysfunctions are a common feature of multiple age-related diseases. However, modeling healthy and pathological aging of the human vasculature represents an unresolved experimental challenge. Here, we generated induced vascular endothelial cells (iVECs) and smooth muscle cells (iSMCs) by direct reprogramming of healthy human fibroblasts from donors of different ages and Hutchinson-Gilford Progeria Syndrome (HGPS) patients. iVECs induced from old donors revealed upregulation of [i]GSTM1[/i] and [i]PALD1[/i], genes linked to oxidative stress, inflammation and endothelial junction stability, as vascular aging markers. A functional assay performed on [i]PALD1[/i] KD VECs demonstrated a recovery in vascular permeability. We found that iSMCs from HGPS donors overexpressed bone morphogenetic protein ([i]BMP[/i])-[i]4[/i], which plays a key role in both vascular calcification and endothelial barrier damage observed in HGPS. Strikingly, [[BMP4]] concentrations are higher in serum from HGPS vs. age-matched mice. Furthermore, targeting [[BMP4]] with blocking antibody recovered the functionality of the vascular barrier in vitro, hence representing a potential future therapeutic strategy to limit cardiovascular dysfunction in HGPS. These results show that iVECs and iSMCs retain disease-related signatures, allowing modeling of vascular aging and HGPS in vitro.

|keywords=* aging
* direct reprogramming
* endothelial cell
* human
* hutchinson-gilford progeria syndrome
* medicine
* mouse
* smooth muscle cell
* vascular barrier
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478891
}}
{{medline-entry
|title=Interplay between Follistatin, Activin A, and [[BMP4]] Signaling Regulates Postnatal Thymic Epithelial Progenitor Cell Differentiation during Aging.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31242421
|abstract=A key feature of immune functional impairment with age is the progressive involution of thymic tissue responsible for naive T cell production. In this study, we identify two major phases of thymic epithelial cell ([[TEC]]) loss during aging: a block in mature [[TEC]] differentiation from the pool of immature precursors, occurring at the onset of puberty, followed by impaired bipotent [[TEC]] progenitor differentiation and depletion of Sca-1  c[[TEC]] and m[[TEC]] lineage-specific precursors. We reveal that an increase in follistatin production by aging [[TEC]]s contributes to their own demise. [[TEC]] loss occurs primarily through the antagonism of activin A signaling, which we show is required for [[TEC]] maturation and acts in dissonance to [[BMP4]], which promotes the maintenance of [[TEC]] progenitors. These results support a model in which an imbalance of activin A and [[BMP4]] signaling underpins the degeneration of postnatal [[TEC]] maintenance during aging, and its reversal enables the transient replenishment of mature [[TEC]]s.
|mesh-terms=* Activins
* Aging
* Animals
* Bone Morphogenetic Protein 4
* Cell Differentiation
* Epithelial Cells
* Female
* Follistatin
* Mice
* Mice, Inbred BALB C
* Signal Transduction
* Stem Cells
* Thymus Gland
|keywords=* BMP4
* activin A
* androgen blockade
* follistatin
* immune aging
* thymic epithelial cells
* thymic epithelial progenitor
* thymic involution
* thymus
* thymus regeneration
|full-text-url=https://sci-hub.do/10.1016/j.celrep.2019.05.045
}}
{{medline-entry
|title=Centenarians Overexpress Pluripotency-Related Genes.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30052797
|abstract=Human mesenchymal cells can become pluripotent by the addition of Yamanaka factors OCT3/4, [[SOX2]], c-[[MYC]], [[KLF4]]. We have recently reported that centenarians overexpress BCL-xL, which has been shown to improve pluripotency; thus, we aimed to determine the expression of pluripotency-related genes in centenarians. We recruited 22 young, 32 octogenarian, and 47 centenarian individuals and determined the mRNA expression of Yamanaka factors and other stemness-related cell surface marker genes ([[VIM]], [[BMP4]], NCAM, [[BMPR2]]) in peripheral blood mononuclear cells by reverse transcription polymerase chain reaction. We found that centenarians overexpress OCT3/4, [[SOX2]], c-[[MYC]], [[VIM]], [[BMP4]], NCAM, and [[BMPR2]], when compared with octogenarians (p < .05). We further tested the functional role of BCL-xL in centenarians' ability to express pluripotency-related genes: lymphocytes from octogenarians transduced with BCL-xL overexpressed [[SOX2]], c-[[MYC]], and [[KLF4]]. We conclude that centenarians overexpress Yamanaka Factors and other stemness-related cell surface marker genes, which may contribute to their successful aging.
|mesh-terms=* Adult
* Age Factors
* Aged, 80 and over
* Aging
* Cells, Cultured
* Cohort Studies
* Female
* Gene Expression Regulation
* Humans
* Leukocytes, Mononuclear
* Male
* Membrane Proteins
* Pluripotent Stem Cells
|keywords=* Healthy aging
* Longevity
* Pluripotency
* Stemness
|full-text-url=https://sci-hub.do/10.1093/gerona/gly168
}}
{{medline-entry
|title=BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27794120
|abstract=Fibrodysplasia ossificans progressiva (FOP) patients carry a missense mutation in [[ACVR1]] [617G > A (R206H)] that leads to hyperactivation of BMP-SMAD signaling. Contrary to a previous study, here we show that FOP fibroblasts showed an increased efficiency of induced pluripotent stem cell (iPSC) generation. This positive effect was attenuated by inhibitors of BMP-SMAD signaling (Dorsomorphin or LDN1931890) or transducing inhibitory SMADs (SMAD6 or SMAD7). In normal fibroblasts, the efficiency of iPSC generation was enhanced by transducing mutant [[ACVR1]] (617G > A) or [[SMAD1]] or adding [[BMP4]] protein at early times during the reprogramming. In contrast, adding [[BMP4]] at later times decreased iPSC generation. ID genes, transcriptional targets of BMP-SMAD signaling, were critical for iPSC generation. The BMP-SMAD-ID signaling axis suppressed p16/INK4A-mediated cell senescence, a major barrier to reprogramming. These results using patient cells carrying the [[ACVR1]] R206H mutation reveal how cellular signaling and gene expression change during the reprogramming processes.
|mesh-terms=* Activin Receptors, Type I
* Adolescent
* Adult
* Animals
* Bone Morphogenetic Proteins
* Cell Line
* Cellular Reprogramming
* Cellular Senescence
* Child
* Cyclin-Dependent Kinase Inhibitor p16
* Female
* Fibroblasts
* Humans
* Induced Pluripotent Stem Cells
* Male
* Mice, Transgenic
* Middle Aged
* Mutation
* Myositis Ossificans
* Signal Transduction
* Smad Proteins
|keywords=* BMP
* FOP
* pluripotency
* reprogramming
* senescence
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135304
}}
{{medline-entry
|title=Increased bone morphogenetic protein signaling contributes to age-related declines in neurogenesis and cognition.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26827654
|abstract=Aging is associated with decreased neurogenesis in the hippocampus and diminished hippocampus-dependent cognitive functions. Expression of bone morphogenetic protein 4 ([[BMP4]]) increases with age by more than 10-fold in the mouse dentate gyrus while levels of the BMP inhibitor, noggin, decrease. This results in a profound 30-fold increase in phosphorylated-SMAD1/5/8, the effector of canonical BMP signaling. Just as observed in mice, a profound increase in expression of [[BMP4]] is observed in the dentate gyrus of humans with no known cognitive abnormalities. Inhibition of BMP signaling either by overexpression of noggin or transgenic manipulation not only increases neurogenesis in aging mice, but remarkably, is associated with a rescue of cognitive deficits to levels comparable to young mice. Additive benefits are observed when combining inhibition of BMP signaling and environmental enrichment. These findings indicate that increased BMP signaling contributes significantly to impairments in neurogenesis and to cognitive decline associated with aging, and identify this pathway as a potential druggable target for reversing age-related changes in cognition. 
|mesh-terms=* Aging
* Animals
* Bone Morphogenetic Protein 4
* Carrier Proteins
* Cognition
* Cognition Disorders
* Dentate Gyrus
* Gene Expression
* Hippocampus
* Humans
* Male
* Mice, Inbred C57BL
* Molecular Targeted Therapy
* Neurogenesis
* Signal Transduction
|keywords=* Aging
* Dentate gyrus
* Environmental enrichment
* Neural stem cell
* Novel object recognition
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735642
}}
{{medline-entry
|title=Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25967096
|abstract=The PC3/Tis21/Btg2 and Btg1 genes are transcriptional cofactors belonging to the Btg/Tob family, which regulate the development of several cell types, including neural precursors. We summarize here the actions of these genes on neural precursors in the adult neurogenic niches and the cognitive defects associated when their expression is altered. We consider also recent findings implicating them in neural and non-neural tumors, since common developmental mechanisms are involved. PC3/Tis21 is required for the regulation of the maturation of stem and progenitor cells in the adult dentate gyrus and subventricular zone (SVZ), by controlling both their exit from the cell cycle and the ensuing terminal differentiation. Such actions are effected by regulating the expression of several genes, including cyclin D1, [[BMP4]], Id3. In cerebellar precursors, however, PC3/Tis21 regulates chiefly their migration rather than proliferation or differentiation, with important implications for the onset of medulloblastoma, the cerebellar tumor. In fact PC3/Tis21 is a medulloblastoma-suppressor, as its overexpression in cerebellar precursors inhibits this tumor; PC3/Tis21 shows anti-tumor activity also in non-neural tumors. Btg1 presents a different functional profile, as it controls proliferation in adult stem/progenitor cells of dentate gyrus and SVZ, where is required to maintain their self-renewal and quiescence, but is apparently devoid of a direct control of their terminal differentiation or migration. Notably, physical exercise in Btg1-null mice rescues the loss of proliferative capability occurring in older stem cells. Both genes could be further investigated as therapeutical targets, namely, Btg1 in the process of aging and PC3/Tis21 as a tumor-suppressor.
|mesh-terms=* Aging
* Animals
* Brain
* Brain Neoplasms
* Cell Cycle
* Gene Expression Regulation, Developmental
* Humans
* Immediate-Early Proteins
* Neoplasm Proteins
* Neural Stem Cells
* Neurogenesis
* Signal Transduction
* Transcription Factors
* Transcription, Genetic
* Tumor Suppressor Proteins

|full-text-url=https://sci-hub.do/10.1002/jcp.25038
}}
{{medline-entry
|title=FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure, aging, and cancer.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25269615
|abstract=Despite extensive research, genetic basis of premature ovarian failure (POF) and ovarian cancer still remains elusive. It is indeed paradoxical that scientists searched for mutations in FSH receptor (FSHR) expressed on granulosa cells, whereas more than 90% of cancers arise in ovary surface epithelium (OSE). Two distinct populations of stem cells including very small embryonic-like stem cells (VSELs) and ovarian stem cells (OSCs) exist in OSE, are responsible for neo-oogenesis and primordial follicle assembly in adult life, and are modulated by FSH via its alternatively spliced receptor variant FSHR3 (growth factor type 1 receptor acting via calcium signaling and the ERK/MAPK pathway). Any defect in FSH-FSHR3-stem cell interaction in OSE may affect folliculogenesis and thus result in POF. Ovarian aging is associated with a compromised microenvironment that does not support stem cell differentiation into oocytes and further folliculogenesis. FSH exerts a mitogenic effect on OSE and elevated FSH levels associated with advanced age may provide a continuous trigger for stem cells to proliferate resulting in cancer, thus supporting gonadotropin theory for ovarian cancer. Present review is an attempt to put adult ovarian biology, POF, aging, and cancer in the perspective of FSH-FSHR3-stem cell network that functions in OSE. This hypothesis is further supported by the recent understanding that: i) cancer is a stem cell disease and OSE is the niche for ovarian cancer stem cells; ii) ovarian OCT4-positive stem cells are regulated by FSH; and iii) OCT4 along with LIN28 and [[BMP4]] are highly expressed in ovarian cancers. 
|mesh-terms=* Adult
* Aging
* Epithelium
* Female
* Follicle Stimulating Hormone, Human
* Humans
* Mutation
* Ovarian Neoplasms
* Ovary
* Primary Ovarian Insufficiency
* Receptors, FSH
* Stem Cells

|full-text-url=https://sci-hub.do/10.1530/REP-14-0220
}}
{{medline-entry
|title=Molecular cloning and expression analysis of prostaglandin E receptor 2 gene in cashmere goat (Capra hircus) skin during hair follicle development.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24555795
|abstract=As a member of the four subtypes of receptors for prostaglandin E2 (PGE2), prostaglandin E receptor 2 ([[PTGER2]]) is in the family of G-protein coupled receptors and has been characterized to be involved in the development and growth of hair follicles. In this study, we cloned and characterized the full-length coding sequence (CDS) of [[PTGER2]] gene from cashmere goat skin. The entire open reading frame (ORF) of [[PTGER2]] gene was 1047 bp and encoded 348 amino acid residues. The deduced protein contained one G-protein coupled receptors family 1 signature, seven transmembrane domains, and other potential sites. Tissue expression analysis showed that [[PTGER2]] gene was expressed strongly in the skin. The general expression tendency of [[PTGER2]] gene at different hair follicle developmental stages in the skin was gradually decreased from anagen to catagen to telogen. After comparing with the expression of [[BMP4]] gene and related reports, we further presume that it seems to have a relationship between the hair follicle cycle and the expression level of [[PTGER2]] gene in cashmere goat skin. 
|mesh-terms=* Aging
* Amino Acid Sequence
* Animals
* Base Sequence
* Cloning, Molecular
* Gene Expression Profiling
* Gene Expression Regulation, Developmental
* Goats
* Hair Follicle
* Molecular Sequence Data
* Organ Specificity
* Receptors, Prostaglandin E, EP2 Subtype
* Tissue Distribution

|full-text-url=https://sci-hub.do/10.1080/10495398.2013.826236
}}
{{medline-entry
|title=What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of [[BMP4]] induced senescence.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/20157553
|abstract=Age-related macular degeneration (AMD), the leading cause of blindness in the elderly, targets the retinal pigment epithelium ([[RPE]]), a monolayer of cells at the back of the eye. As AMD progresses, it can develop into two distinct forms of late AMD: "dry," atrophic AMD, characterized by [[RPE]] senescence and geographic [[RPE]] loss, and "wet," neovascular AMD, characterized by [[RPE]] activation with abnormal growth of choroidal vessels. The genetic and molecular pathways that lead to these diverse phenotypes are currently under investigation. We have found that bone morphogenetic protein-4 ([[BMP4]]) is differentially expressed in atrophic and neovascular AMD. In atrophic AMD, [[BMP4]] is highly expressed in [[RPE]], and mediates oxidative stress induced [[RPE]] senescencein vitro via Smad and p38 pathways. In contrast, in neovascular AMD lesions, [[BMP4]] expression in [[RPE]] is low, possibly a result of local expression of pro-inflammatory mediators. Thus, [[BMP4]] may be involved in the molecular switch determining which phenotypic pathway is taken in the progression of AMD.
|mesh-terms=* Aging
* Bone Morphogenetic Protein 4
* Cellular Senescence
* Cyclin-Dependent Kinase Inhibitor p21
* Humans
* Hydrogen Peroxide
* Interleukin-8
* Macular Degeneration
* Oxidative Stress
* Retinal Neovascularization
* Retinal Pigment Epithelium
* Smad Proteins
* p38 Mitogen-Activated Protein Kinases
|keywords=* BMP4
* age related macular degeneration
* oxidative stress
* retinal pigment epithelial cell
* senescence
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806048
}}
{{medline-entry
|title=Selection of common markers for bone marrow stromal cells from various bones using real-time RT-PCR: effects of passage number and donor age.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/17596118
|abstract=Bone marrow stromal cells (BMSCs) are valuable in tissue engineering and cell therapy, but the quality of the cells is critical for the efficacy of therapy. To test the quality and identity of transplantable cells, we identified the molecular markers that were expressed at higher levels in BMSCs than in fibroblasts. Using numerous BMSC lines from tibia, femur, ilium, and jaw, together with skin and gum fibroblasts, we compared the gene expression profiles of these cells using DNA microarrays and low-density array cards. The differentiation potential of tibia and femur BMSCs was similar to that of iliac BMSCs, and different from jaw BMSCs, but all BMSC lines had many common markers that were expressed at much higher levels in BMSCs than in fibroblasts; several BMSC markers showed discrete expression patterns between jaw and other BMSCs. The common markers are probably useful in routine tests, but their efficacy may depend upon the passage number or donor age. In our study the passage number markedly altered the expression levels of several markers, while donor age had little effect on them. Considering the effects of in vivo location of BMSCs and passage, magnitude of increase in expression levels, and interindividual differences, we identified several reliable markers -- [[LIF]], [[IGF1]], PRG1, [[MGP]], [[BMP4]], CTGF, [[KCTD12]], [[IGFBP7]], [[TRIB2]], and [[DYNC1I1]] -- among many candidates. This marker set may be useful in a routine test for BMSCs in tissue engineering and cell therapy.
|mesh-terms=* Adult
* Aging
* Biomarkers
* Bone Marrow Cells
* Cell Differentiation
* Cells, Cultured
* Female
* Gene Expression Profiling
* Humans
* Male
* Mesenchymal Stem Cells
* Middle Aged
* Reverse Transcriptase Polymerase Chain Reaction
* Stromal Cells
* Tissue Donors

|full-text-url=https://sci-hub.do/10.1089/ten.2006.0340
}}
{{medline-entry
|title=Evidence for expansion-based temporal [[BMP4]]/NOGGIN interactions in specifying periodontium morphogenesis.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/17618464
|abstract=Dental follicle cells in the periodontium are known to have the ability to differentiate into fibroblasts, cementoblasts, and osteoblasts during mouse periodontal development. From embryonic day 14 (E14) to postnatal day 11 (PN11), histological observations showed dramatic alterations in the relative width of the periodontal ligament (PDL)-forming region between the alveolar bone-forming and tooth root-forming area. At PN2, the width of the PDL-forming region showed a minimum, but with a higher expression of NOGGIN and proliferation cell nuclear antigen than the other regions. At PN11, the relative width of the PDL-forming region had expanded. Transplantation of individual regions of the developing tooth germ under the kidney renal capsule showed that dental follicle cells at E14 possessed the potential to develop into mineralized tissue after 3 weeks. These results suggested that the recovery of PDL width at PN11 may have resulted from cell proliferation and molecular interactions between osteogenic factors and their antagonists, such as interactions between bone morphogenetic protein 4 ([[BMP4]]) and NOGGIN, simlilar to those observed in suture, limb, and somite formation. To confirm the molecular interaction between [[BMP4]] and NOGGIN, NOGGIN-protein bead implantation onto cultures was employed in vitro. This study thus indicates that harmonious interactions between NOGGIN and BMP in PDL-forming cells, which show higher cell proliferation than neighboring cells, might be important for proper periodontium development.
|mesh-terms=* Aging
* Animals
* Animals, Newborn
* Bone Morphogenetic Protein 4
* Bone Morphogenetic Proteins
* Carrier Proteins
* Cell Division
* Dental Sac
* Embryonic Development
* Mice
* Mice, Inbred ICR
* Molar
* Morphogenesis
* Osteogenesis
* Periodontium
* Proliferating Cell Nuclear Antigen
* Subrenal Capsule Assay

|full-text-url=https://sci-hub.do/10.1007/s00441-007-0434-2
}}
{{medline-entry
|title=Spatial and temporal patterns of expression of Noggin and [[BMP4]] in embryonic and postnatal rat hippocampus.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/14643011
|abstract=Recent studies indicate that bone morphogenetic protein-4 ([[BMP4]]) and Noggin not only play an important role in the early development of the nervous system, but may also play a role in postnatal central nervous system (CNS) development. In this study, we examined the relative levels and localization of Noggin and [[BMP4]] mRNA in the hippocampus of rats of different developmental stages with reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH). RT-PCR showed that the temporal changes in the levels of expression of Noggin and [[BMP4]] were different. The peak level of expression of Noggin mRNA was observed at embryonic day 13 (E13), subsequently gradually declined at 1-3 months (P1-3M) postnatal, and was detected only at a low level at P18M. In contrast, the expression of [[BMP4]] mRNA increased gradually during embryonic development, reached a maximal level at 3 weeks (W) postnatal, and declined only slightly through P18M. In situ hybridization revealed that at embryonic stages, Noggin mRNA was localized throughout all hippocampal regions, whereas at early postnatal ages, Noggin mRNA was primarily localized in the anterior subiculum. At embryonic and early postnatal stages, no significant [[BMP4]] mRNA expression was detectable in the hippocampus. At later postnatal ages, however, Noggin and [[BMP4]] mRNA expression was observed in similar patterns. At 1-3 months postnatal, expression of [[BMP4]] was observed mainly in the dentate gyrus and in the [[CA1]]-[[CA3]] pyramidal cell layers. Lower hybridization signals were observed in the hilus and subiculum. Taken together, our results demonstrate that Noggin and [[BMP4]] are expressed in embryonic and postnatal hippocampus, and that the temporal and spatial patterns of their expression are developmentally regulated. These data suggest that Noggin and [[BMP4]] play important roles in hippocampal development.
|mesh-terms=* Aging
* Animals
* Animals, Newborn
* Blotting, Northern
* Bone Morphogenetic Protein 4
* Bone Morphogenetic Proteins
* Carrier Proteins
* Embryo, Mammalian
* Gene Expression Regulation, Developmental
* Hippocampus
* In Situ Hybridization
* Proteins
* RNA, Messenger
* Rats
* Rats, Sprague-Dawley
* Reverse Transcriptase Polymerase Chain Reaction

|full-text-url=https://sci-hub.do/10.1016/j.devbrainres.2003.09.007
}}